[HTML][HTML] Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

N Ahmadi Bidakhvidi, A Laenen, S Jentjens… - EJNMMI research, 2021 - Springer
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

Parameters predicting [18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

NA Bidakhvidi, A Laenen, S Jentjens… - EJNMMI …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

Parameters predicting [18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.

N Ahmadi Bidakhvidi, A Laenen, S Jentjens… - EJNMMI …, 2021 - search.ebscohost.com
Background: Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

Parameters predicting [18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

BN Ahmadi, L Annouschka, J Sander… - EJNMMI …, 2021 - search.proquest.com
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

[HTML][HTML] Parameters predicting [18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

N Ahmadi Bidakhvidi, A Laenen… - EJNMMI …, 2021 - ejnmmires.springeropen.com
Detection of the site of recurrence using PSMA-PET/CT is important to guide treatment in
patients with biochemical recurrence of prostate cancer (PCa). The aim of this study was to …

Parameters predicting [18F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.

A Laenen, S Jentjens, CM Deroose, K Van Laere… - EJNMMI …, 2021 - europepmc.org
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

[PDF][PDF] Parameters predicting [18 F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

NA Bidakhvidi, A Laenen, S Jentjens, CM Deroose… - 2021 - lirias.kuleuven.be
Background: Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

[HTML][HTML] Parameters predicting [18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

NA Bidakhvidi, A Laenen, S Jentjens… - EJNMMI …, 2021 - ncbi.nlm.nih.gov
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

[PDF][PDF] Parameters predicting [18 F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer

NA Bidakhvidi, A Laenen, S Jentjens, CM Deroose… - 2021 - scholar.archive.org
Background: Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …

Parameters predicting [. sup. 18F] PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.

NA Bidakhvidi, A Laenen, S Jentjens, CM Deroose… - EJNMMI …, 2021 - go.gale.com
Background Detection of the site of recurrence using PSMA-PET/CT is important to guide
treatment in patients with biochemical recurrence of prostate cancer (PCa). The aim of this …